• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症患者大脑中高亲和力谷氨酸摄取位点减少。

Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.

作者信息

Cross A J, Slater P, Reynolds G P

出版信息

Neurosci Lett. 1986 Jun 18;67(2):198-202. doi: 10.1016/0304-3940(86)90397-6.

DOI:10.1016/0304-3940(86)90397-6
PMID:2873534
Abstract

The binding of D-[3H]aspartic acid to the high-affinity glutamate uptake system was studied in membrane preparations of postmortem brains from controls and Huntington's disease (HD) subjects. The groups were matched for age and postmortem delay. A large (60-72%) and significant reduction in D-[3H]aspartate binding was observed in both the caudate nucleus and putamen, but not in the frontal cortex of the HD brains. The loss of striatal D-[3H]aspartate binding may reflect a loss of the high-affinity glutamate uptake system contained on the terminals of corticostriatal afferents. In contrast, the binding of [3H]paroxetine to the serotonin uptake system was marginally increased in the caudate nucleus and unchanged in the putamen. It is suggested that the reduction of high-affinity glutamate uptake sites may contribute to the production of the striatal lesion in HD.

摘要

在来自对照组和亨廷顿舞蹈症(HD)患者的死后大脑膜制剂中,研究了D-[3H]天冬氨酸与高亲和力谷氨酸摄取系统的结合情况。两组在年龄和死后延迟方面相匹配。在HD大脑的尾状核和壳核中,观察到D-[3H]天冬氨酸结合大幅(60 - 72%)且显著减少,但在额叶皮质中未出现这种情况。纹状体中D-[3H]天冬氨酸结合的丧失可能反映了皮质纹状体传入神经末梢上所含高亲和力谷氨酸摄取系统的丧失。相比之下,[3H]帕罗西汀与5-羟色胺摄取系统的结合在尾状核中略有增加,在壳核中则无变化。有人提出,高亲和力谷氨酸摄取位点的减少可能促成了HD中纹状体病变的产生。

相似文献

1
Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.亨廷顿舞蹈症患者大脑中高亲和力谷氨酸摄取位点减少。
Neurosci Lett. 1986 Jun 18;67(2):198-202. doi: 10.1016/0304-3940(86)90397-6.
2
Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.阿尔茨海默病和亨廷顿病中L-谷氨酸结合的改变。
Science. 1985 Mar 22;227(4693):1496-9. doi: 10.1126/science.2858129.
3
Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.亨廷顿病患者大脑中红藻氨酸受体结合位点减少。
Biol Psychiatry. 1981 Feb;16(2):155-62.
4
Deficit of [3H]L-689,560 binding to the glycine site of the glutamate/NMDA receptor in the brain in Huntington's disease.亨廷顿病患者大脑中与谷氨酸/N-甲基-D-天冬氨酸受体甘氨酸位点结合的[3H]L-689,560存在缺失。
J Neurol Sci. 1994 Aug;125(1):46-9. doi: 10.1016/0022-510x(94)90240-2.
5
Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease.阿尔茨海默病中突触前和突触后谷氨酸能功能的区域分布
Brain Res. 1988 Jun 14;452(1-2):403-7. doi: 10.1016/0006-8993(88)90048-0.
6
In vivo high-affinity uptake and axonal transport of D-[2,3-3H]aspartate in excitatory neurons.
Brain Res. 1981 Dec 28;230(1-2):427-33. doi: 10.1016/0006-8993(81)90428-5.
7
Huntington's disease: studies on brain free amino acids.亨廷顿舞蹈症:关于脑游离氨基酸的研究
Life Sci. 1988;42(11):1153-8. doi: 10.1016/0024-3205(88)90610-8.
8
Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.无症状基因携带者和亨廷顿病患者的纹状体葡萄糖代谢及多巴胺D2受体结合情况
Brain. 1996 Dec;119 ( Pt 6):2085-95. doi: 10.1093/brain/119.6.2085.
9
What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies.在亨廷顿舞蹈症中,是哪种兴奋性毒素杀死了纹状体神经元?来自神经化学研究的线索。
Neurology. 1990 Jan;40(1):20-4. doi: 10.1212/wnl.40.1.20.
10
[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia.
J Neurochem. 1995 Mar;64(3):1197-202. doi: 10.1046/j.1471-4159.1995.64031197.x.

引用本文的文献

1
Single-nuclei transcriptome analysis of Huntington disease iPSC and mouse astrocytes implicates maturation and functional deficits.亨廷顿病诱导多能干细胞和小鼠星形胶质细胞的单核转录组分析揭示了成熟和功能缺陷。
iScience. 2022 Dec 6;26(1):105732. doi: 10.1016/j.isci.2022.105732. eCollection 2023 Jan 20.
2
Neurotransmitter Release of Reprogrammed Cells Using Electrochemical Detection Methods.使用电化学检测方法检测重编程细胞的神经递质释放。
Methods Mol Biol. 2021;2352:201-226. doi: 10.1007/978-1-0716-1601-7_14.
3
Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
星形胶质细胞中突变亨廷顿蛋白的减少减缓了 BACHD 条件性亨廷顿病小鼠模型的疾病进展。
Hum Mol Genet. 2019 Feb 1;28(3):487-500. doi: 10.1093/hmg/ddy363.
4
The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders.谷氨酸转运体在神经精神疾病病理生理学中的作用。
NPJ Schizophr. 2017 Sep 21;3(1):32. doi: 10.1038/s41537-017-0037-1.
5
Corticostriatal Dysfunction in Huntington's Disease: The Basics.亨廷顿舞蹈病中的皮质纹状体功能障碍:基础
Front Hum Neurosci. 2016 Jun 28;10:317. doi: 10.3389/fnhum.2016.00317. eCollection 2016.
6
GLT-1: The elusive presynaptic glutamate transporter.谷氨酸转运体-1:难以捉摸的突触前谷氨酸转运蛋白。
Neurochem Int. 2016 Sep;98:19-28. doi: 10.1016/j.neuint.2016.04.010. Epub 2016 Apr 26.
7
Translational potential of astrocytes in brain disorders.星形胶质细胞在脑部疾病中的转化潜力。
Prog Neurobiol. 2016 Sep;144:188-205. doi: 10.1016/j.pneurobio.2015.09.003. Epub 2015 Sep 16.
8
Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression.亨廷顿病 R6/2 模型中 GLT-1 表达降低不会加重疾病进展。
Eur J Neurosci. 2013 Aug;38(3):2477-90. doi: 10.1111/ejn.12202. Epub 2013 Apr 16.
9
Role of cerebral cortex in the neuropathology of Huntington's disease.大脑皮层在亨廷顿病神经病理学中的作用。
Front Neural Circuits. 2013 Feb 18;7:19. doi: 10.3389/fncir.2013.00019. eCollection 2013.
10
Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes.亨廷顿舞蹈病中的皮质纹状体功能障碍与谷氨酸转运体1(GLT1):神经元与星形胶质细胞之间的相互作用
Basal Ganglia. 2012 Jul 1;2(2):57-66. doi: 10.1016/j.baga.2012.04.029.